Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease

[1]  Haitao Wang,et al.  FFPM, a PDE4 inhibitor, reverses learning and memory deficits in APP/PS1 transgenic mice via cAMP/PKA/CREB signaling and anti-inflammatory effects , 2017, Neuropharmacology.

[2]  L. Milanesi,et al.  New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment. , 2016, European journal of medicinal chemistry.

[3]  A. Blokland,et al.  The PDE4 inhibitor roflumilast improves memory in rodents at non-emetic doses , 2016, Behavioural Brain Research.

[4]  E. Fedele,et al.  Phosphodiesterase 4D: an enzyme to remember , 2015, British journal of pharmacology.

[5]  E. Fedele,et al.  Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitors. , 2015, Bioorganic & medicinal chemistry.

[6]  A. Palmeri,et al.  A key role for TGF-β1 in hippocampal synaptic plasticity and memory , 2015, Scientific Reports.

[7]  A. Blokland,et al.  PDE and cognitive processing: Beyond the memory domain , 2015, Neurobiology of Learning and Memory.

[8]  Rolf T Hansen,et al.  Phosphodiesterase-4 modulation as a potential therapeutic for cognitive loss in pathological and non-pathological aging: possibilities and pitfalls. , 2014, Current pharmaceutical design.

[9]  P. Heckman,et al.  Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer's disease: a translational overview. , 2014, Current pharmaceutical design.

[10]  E. Fedele,et al.  Synthesis, biological evaluation, and molecular modeling of new 3-(cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) Oxime (GEBR-7b) related phosphodiesterase 4D (PDE4D) inhibitors. , 2014, Journal of medicinal chemistry.

[11]  C. Dominguez,et al.  Efficacy of Selective PDE4D Negative Allosteric Modulators in the Object Retrieval Task in Female Cynomolgus Monkeys (Macaca fascicularis) , 2014, PloS one.

[12]  R. D'Hooge,et al.  Improved Long-Term Memory via Enhancing cGMP-PKG Signaling Requires cAMP-PKA Signaling , 2014, Neuropsychopharmacology.

[13]  Hong Liu,et al.  Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011). , 2014, Chemical reviews.

[14]  E. Fedele,et al.  Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D , 2014, Neuropharmacology.

[15]  N. Meanwell,et al.  Tactical Applications of Fluorine in Drug Design and Development , 2014 .

[16]  M. Gurney,et al.  Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer’s Disease , 2014, Neurotherapeutics.

[17]  Thomas M. Sanderson,et al.  The role of phosphodiesterases in hippocampal synaptic plasticity , 2013, Neuropharmacology.

[18]  S. Meuth,et al.  The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood–brain-barrier damage, inflammation and thrombosis , 2013, Experimental Neurology.

[19]  F. Menniti,et al.  PDE4 as a target for cognition enhancement , 2013, Expert opinion on therapeutic targets.

[20]  Hongbing Wang,et al.  Mice overexpressing type 1 adenylyl cyclase show enhanced spatial memory flexibility in the absence of intact synaptic long-term depression , 2013, Learning & memory.

[21]  S. Kida.  A Functional Role for CREB as a Positive Regulator of Memory Formation and LTP , 2012, Experimental neurobiology.

[22]  Jos Prickaerts,et al.  Object recognition testing: Statistical considerations , 2012, Behavioural Brain Research.

[23]  A. Blokland,et al.  Object recognition testing: Methodological considerations on exploration and discrimination measures , 2012, Behavioural Brain Research.

[24]  Eric R Kandel,et al.  The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB , 2012, Molecular Brain.

[25]  D. Manahan‐Vaughan,et al.  PDE4 inhibition enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced impairment of long-term potentiation and object recognition memory in an animal model of psychosis , 2012, Translational Psychiatry.

[26]  E. Fedele,et al.  GEBR‐7b, a novel PDE4D selective inhibitor that improves memory in rodents at non‐emetic doses , 2011, British journal of pharmacology.

[27]  M. Zhuo,et al.  Upregulation of CREB-Mediated Transcription Enhances Both Short- and Long-Term Memory , 2011, The Journal of Neuroscience.

[28]  E. Fedele,et al.  Alterations of glutamate release in the spinal cord of mice with experimental autoimmune encephalomyelitis , 2010, Journal of neurochemistry.

[29]  Timothy Hagen,et al.  Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety , 2010, Nature Biotechnology.

[30]  C. Brullo,et al.  New selective phosphodiesterase 4D inhibitors differently acting on long, short, and supershort isoforms. , 2009, Journal of medicinal chemistry.

[31]  T. Abel,et al.  Exchange protein activated by cAMP enhances long-term memory formation independent of protein kinase A. , 2009, Learning & memory.

[32]  P. Kelly,et al.  Phosphodiesterase Inhibitors Enhance Object Memory Independent of Cerebral Blood Flow and Glucose Utilization in Rats , 2009, Neuropsychopharmacology.

[33]  W. Hagmann,et al.  The many roles for fluorine in medicinal chemistry. , 2008, Journal of medicinal chemistry.

[34]  Eric Klann,et al.  Activation of exchange protein activated by cyclic-AMP enhances long-lasting synaptic potentiation in the hippocampus. , 2008, Learning & memory.

[35]  F. Diederich,et al.  Fluorine in Pharmaceuticals: Looking Beyond Intuition , 2007, Science.

[36]  F. J. van der Staay,et al.  Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. , 2007, European journal of pharmacology.

[37]  Sydney Brenner,et al.  Changes in PDE4D isoforms in the hippocampus of a patient with advanced Alzheimer disease. , 2007, Archives of neurology.

[38]  P. Davies,et al.  Troglitazone, a peroxisome proliferator‐activated receptor‐γ agonist, decreases tau phosphorylation in CHOtau4R cells , 2006, Journal of neurochemistry.

[39]  T. Abel,et al.  Metaplasticity of the late‐phase of long‐term potentiation: a critical role for protein kinase A in synaptic tagging , 2006, The European journal of neuroscience.

[40]  A. Janzen,et al.  Possibilities and Pitfalls , 2005 .

[41]  Devang Akotia Barbara Barry Bautista Jennifer Natasha Bri Alfa.  Reversible Inhibition of CREB / ATF Transcription Factors in Region CA 1 of the Dorsal Hippocampus Disrupts Hippocampus Dependent Spatial Memory , 2005 .

[42]  O. Vitolo,et al.  Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. , 2004, The Journal of clinical investigation.

[43]  D. Storm,et al.  Overexpression of type-1 adenylyl cyclase in mouse forebrain enhances recognition memory and LTP , 2004, Nature Neuroscience.

[44]  O. Vitolo,et al.  Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Eric R. Kandel,et al.  Reversible Inhibition of CREB/ATF Transcription Factors in Region CA1 of the Dorsal Hippocampus Disrupts Hippocampus-Dependent Spatial Memory , 2002, Neuron.

[46]  Eric R. Kandel,et al.  Expression of Constitutively Active CREB Protein Facilitates the Late Phase of Long-Term Potentiation by Enhancing Synaptic Capture , 2002, Cell.

[47]  C. Chan,et al.  Assessing the emetic potential of PDE4 inhibitors in rats , 2002, British journal of pharmacology.

[48]  M. T. Koh,et al.  Inhibition of protein kinase A activity interferes with long-term, but not short-term, memory of conditioned taste aversions. , 2002, Behavioral neuroscience.

[49]  C. Chan,et al.  PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway , 2001, Neuropharmacology.

[50]  N. Kitteringham,et al.  Metabolism of fluorine-containing drugs. , 2001, Annual review of pharmacology and toxicology.

[51]  Louis J Muglia,et al.  Calcium-Stimulated Adenylyl Cyclase Activity Is Critical for Hippocampus-Dependent Long-Term Memory and Late Phase LTP , 1999, Neuron.

[52]  E. Kandel,et al.  Genetic Demonstration of a Role for PKA in the Late Phase of LTP and in Hippocampus-Based Long-Term Memory , 1997, Cell.

[53]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[54]  E. Kandel,et al.  Recruitment of long-lasting and protein kinase A-dependent long-term potentiation in the CA1 region of hippocampus requires repeated tetanization. , 1994, Learning & memory.

[55]  E. Kandel,et al.  Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. , 1993, Science.

[56]  A. Ennaceur,et al.  A new one-trial test for neurobiological studies of memory in rats. III. Spatial vs. non-spatial working memory , 1992, Behavioural Brain Research.

[57]  N. Geyer,et al.  Rolipram in Major Depressive Disorder: Results of a Double-Blind Comparative Study with Imipramine , 1989, Pharmacopsychiatry.

[58]  J. Delacour,et al.  A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data , 1988, Behavioural Brain Research.

[59]  W. Krause,et al.  Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.

[60]  T. Bliss,et al.  Long‐lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path , 1973, The Journal of physiology.